This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
03/30/15 - 9:52:33 AM ET (BATS BZX Real-time Price)
Div Yield: --
AEGR Day's Range
AEGR 52 Week Range
AEGR Business Summary
Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States.View AEGR key stats
Aegerion Pharmaceuticals Inc - AEGR - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Aegerion Pharmaceuticals Inc as a
Sell with a ratings score of D.
Report Snippet: We rate Aegerion Pharmaceuticals Inc (AEGR) a Sell.
This is based on the convergence of positive investment measures, which should help this stock outperform the majority
of stocks that we rate. The company's strengths can be seen in multiple areas, such as its solid stock price performance,
growth in earnings per share, revenue growth, notable return on equity and expanding profit margins. Although the company
may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.